Skip to main content

Lifecore Biomedical, Inc.

LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001005286

No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Lifecore Biomedical, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of LFCR: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders8276−6
Shares20.7M24.8M+4.11M (+19.9%)
Value$117.0M$202.4M+$85.4M (+73.0%)

New holders (13)

Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to LFCR in Q4 2024
InstitutionSharesValue% of portfolio
Invesco Ltd.555,607$4.13M0.00%
Falcon Edge Capital, LP116,538$865.9K0.40%
Rangeley Capital, LLC43,700$324.7K0.31%
Massmutual Trust Co FSB28,100$208.8K0.01%
Lepercq De Neuflize Asset Management LLC22,700$168.7K0.12%
MetLife Investment Management14,513$107.8K0.00%
Prudential Financial Inc12,735$94.6K0.00%
Intech Investment Management LLC11,263$83.7K0.00%
ARS Investment Partners, LLC10,000$74.3K0.01%
Police & Firemen's Retirement System of New Jersey5,710$42.4K0.00%
Smartleaf Asset Management LLC620$4.60K0.00%
EverSource Wealth Advisors, LLC18$1340.00%
IFP Advisors, Inc1$70.00%

Sold out (19)

Institutions that held Lifecore Biomedical, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.